Mycoplasma pneumoniae 結果共4筆

Chinese children are increasingly experiencing antibiotic resistance when treating Mycoplasma pneumoniae, which poses a global health and economic concern. By 2050, drug-resistant diseases could result in healthcare costs of NT＄31 trillion and economic losses of up to NT＄106 trillion, according to the World Bank. The overuse of antibiotics has led to the rise of superbugs, diminishing the effectiveness of these medicines and compromising treatment outcomes. Azithromycin, a commonly used antibiotic in China for Mycoplasma pneumoniae, now faces an alarming resistance rate of nearly 80% to Macrolides. The World Health Organization (WHO) warns of the dangers of antibiotic overuse and refers to the situation as a ＂silent pandemic.＂ WHO Director-General Tedros Adhanom Ghebreyesus expresses concern that antibiotic resistance could bring us back to an era where minor infections are untreatable.

The Taiwan Centers for Disease Control (CDC) has reported the first case of Mycoplasma pneumoniae infection in a child detected during airport screening. A teenage boy developed a fever upon arriving from mainland China on December 4 and tested positive for the pathogen the following day. This detection has raised concerns amid an outbreak of respiratory illnesses in mainland China. The CDC has initiated targeted surveillance at the country’s four major international airports, urging travelers to undergo voluntary testing. Mycoplasma pneumoniae infections account for only 1.2 percent of the cases identified through airport screenings, indicating a downward trend overall. The current respiratory diseases in mainland China are predominantly attributed to influenza viruses, with Mycoplasma infections declining. Health officials have reassured the public that airport testing protocols will continue and are expected to be maintained through the Lunar New Year period to ensure monitoring of incoming travelers and the containment of potential infectious diseases.

Taiwanese seniors over 65 can now receive free pneumococcal vaccinations amid a respiratory disease outbreak. The CDC encourages vaccinations against adenoviruses, mycoplasma pneumoniae, the COVID-19 XBB variant, and influenza to bolster the country’s defenses.

黴漿菌肺炎各案頻傳，醫師黃軒指出，不只在中國大陸，丹麥、瑞典、韓國個案數都明顯上升，目前在韓國，每周約有100例黴漿菌肺炎(Mycoplasma pneumoniae)新病例出現，且大多數患者是兒童和年輕人，有8成住院患者年齡在1歲至12歲間，當防疫禁令解除，民眾不再遵守防疫規範，病毒就容易爆發流行，把過去未流行的數量補回來，此現象即是免疫負債，更提醒「這種病原體的再次出現可能會導致嚴重疾病的罕見病例增加，但目前尚不清楚其是否會導致大規模的感染浪潮。」